Panel Discussion: The Role of Data, AI and Emerging Technologies in Reshaping Clinical Trials: Less Burden, More Insight

Time: 4:40PM - 5:30PM

Date: 7 October 2025 Block 6

Synopsis

While digital innovation has enabled continuous remote monitoring and enhanced data accuracy, the economic turbulence means senior leaders are facing mounting
pressure to prove the ROI from AI and other emerging technologies.
This panel will explore how we can move beyond just the tech, focusing on genuinely connecting with patients, understanding their ongoing challenges, and
successfully easing their burden through smarter data approaches.
• Elevating Patient Experience with Continuous Data: Leverage ongoing patient data to personalize trials, enhance comfort, and improve digital tool usability
• Proving ROI & Achieve Cost Efficiency: Demonstrating how data insights and AI’s precision drives cost savings and optimizes trial design
• Humanizing Digital Progress & Boosting Engagement: Simplifying data interaction, actively addressing patient adherence, compliance, and usability challenges
• Transforming Trials with Real-World Impact: Showcasing data-driven success while proactively managing data privacy and security
• Overcoming Internal & External Adoption Barriers: Tackling resistance by highlighting patient benefits and building robust data infrastructure.
• Leadership for Data Integration & Patient Burden Reduction: Championing emerging technologies by aligning innovation with organizational goals to ease
patient load.

Speakers

  • Alex Sverdlov Senior Director, Statistical Scientist - Novartis
  • Elias Abou Zeid Principal Data Scientist, AI & Analytics - Novo Nordisk
  • Mackenzie McKinney Associate Director, Clinical Trial Digital Health - Moderna
  • Marc Nephtali Senior Director Digital – Clinical Systems, Pharmacovigilance and Portfolio Management - Moderna

« Back